Get the latest news on Kadimastem stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on KMSTF performance

Latest Kadimastem Stock News | OTC:KMSTF | Benzinga

Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem Ltd

Small Cap

Press Releases

Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS

NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

KMSTF

NLSP

NLSPW

Kadimastem

Comments

Kadimastem Stock News

News

Latest Kadimastem Stock News | OTC:KMSTF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga